HematoRules
@hematorules.bsky.social
Microbiology/Medicine, Internal Medicine, Hematology. BMTU attending Institut Català d’Oncologia
#HSCT #CARTcells #GvHD #ID
#HSCT #CARTcells #GvHD #ID
🚨 OFERTA LABORAL 🚨 Nueva Plaza 🚨
¿Tienes experiencia en Transplante y Terapia Celular?
¿Quieres formar parte de un equipo #ICOnico?
Esta oferta es para ti! 👩🏻⚕️👨🏻⚕️
INSCRÍBETE AQUÍ!
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
icogencat.talentclue.com/ca/node/1203...
¿Tienes experiencia en Transplante y Terapia Celular?
¿Quieres formar parte de un equipo #ICOnico?
Esta oferta es para ti! 👩🏻⚕️👨🏻⚕️
INSCRÍBETE AQUÍ!
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
icogencat.talentclue.com/ca/node/1203...
October 23, 2025 at 4:25 PM
🚨 OFERTA LABORAL 🚨 Nueva Plaza 🚨
¿Tienes experiencia en Transplante y Terapia Celular?
¿Quieres formar parte de un equipo #ICOnico?
Esta oferta es para ti! 👩🏻⚕️👨🏻⚕️
INSCRÍBETE AQUÍ!
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
icogencat.talentclue.com/ca/node/1203...
¿Tienes experiencia en Transplante y Terapia Celular?
¿Quieres formar parte de un equipo #ICOnico?
Esta oferta es para ti! 👩🏻⚕️👨🏻⚕️
INSCRÍBETE AQUÍ!
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
icogencat.talentclue.com/ca/node/1203...
October 9, 2025 at 10:21 AM
#LymphoidWorld
AgoraH Reunion hoy en Madrid!
@sehhematologia.bsky.social #TopHematoRulers! #HematoSpain #HematoMola!
AgoraH Reunion hoy en Madrid!
@sehhematologia.bsky.social #TopHematoRulers! #HematoSpain #HematoMola!
April 11, 2025 at 9:42 AM
#LymphoidWorld
AgoraH Reunion hoy en Madrid!
@sehhematologia.bsky.social #TopHematoRulers! #HematoSpain #HematoMola!
AgoraH Reunion hoy en Madrid!
@sehhematologia.bsky.social #TopHematoRulers! #HematoSpain #HematoMola!
Piropos de verdad! Comentarios que alegran el día y dan sentido al #HematoWorld!
Tratando de inspirar a los #MIR25 desde el ejemplo y los resultados!
5 de mayo! Empieza la selección de plazas! #EligeHematologia! @sehhematologia.bsky.social
Si aún tienes dudas… mis DM están disponibles 24/7
Tratando de inspirar a los #MIR25 desde el ejemplo y los resultados!
5 de mayo! Empieza la selección de plazas! #EligeHematologia! @sehhematologia.bsky.social
Si aún tienes dudas… mis DM están disponibles 24/7
April 10, 2025 at 5:55 PM
Piropos de verdad! Comentarios que alegran el día y dan sentido al #HematoWorld!
Tratando de inspirar a los #MIR25 desde el ejemplo y los resultados!
5 de mayo! Empieza la selección de plazas! #EligeHematologia! @sehhematologia.bsky.social
Si aún tienes dudas… mis DM están disponibles 24/7
Tratando de inspirar a los #MIR25 desde el ejemplo y los resultados!
5 de mayo! Empieza la selección de plazas! #EligeHematologia! @sehhematologia.bsky.social
Si aún tienes dudas… mis DM están disponibles 24/7
New comment on @bloodjournal.bsky.social of our #ICOnic @albertomussetti.bsky.social & @annasureda.bsky.social about Prizloncabtagene autoleucel: New #CART for cell B #Lymphoma!
Available here
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
ashpublications.org/blood/articl...
Available here
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
ashpublications.org/blood/articl...
Prizloncabtagene autoleucel: a new CAR T cell for B-NHL
In this issue of Blood, Yu et al reported promising clinical results of prizloncabtagene autoleucel (prizlon-cel), a next-generation chimeric antigen recep
ashpublications.org
April 3, 2025 at 7:15 PM
New comment on @bloodjournal.bsky.social of our #ICOnic @albertomussetti.bsky.social & @annasureda.bsky.social about Prizloncabtagene autoleucel: New #CART for cell B #Lymphoma!
Available here
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
ashpublications.org/blood/articl...
Available here
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
ashpublications.org/blood/articl...
🚨 NEW #ICOnic PUBLICATION 🚨
Congratulations @martape28.bsky.social et al. For this paper!
Now available online
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
www.nature.com/articles/s41...
Congratulations @martape28.bsky.social et al. For this paper!
Now available online
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
www.nature.com/articles/s41...
Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on behalf of GETH-TC - Bone Marrow Transp...
Bone Marrow Transplantation - Thiotepa, busulfan and fludarabine conditioning regimen for adult patients with lymphoid malignancies undergoing allogeneic stem cell transplantation: a study on...
www.nature.com
April 3, 2025 at 1:43 PM
🚨 NEW #ICOnic PUBLICATION 🚨
Congratulations @martape28.bsky.social et al. For this paper!
Now available online
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
www.nature.com/articles/s41...
Congratulations @martape28.bsky.social et al. For this paper!
Now available online
⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️⬇️
www.nature.com/articles/s41...
Reposted by HematoRules
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
authors.elsevier.com/a/1ks1w5EIIg...
authors.elsevier.com/a/1ks1w5EIIg...
authors.elsevier.com
April 1, 2025 at 5:24 AM
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
authors.elsevier.com/a/1ks1w5EIIg...
authors.elsevier.com/a/1ks1w5EIIg...
Reposted by HematoRules
🚨 New Research Alert! 🚨 A machine learning tool is aiding patients with #myelofibrosis and doctors in making better #transplant decisions! Developed by The EBMT, it outperforms traditional methods. Read more in the press release: www.hematology.org/n...
#Hematology #HemeOnc #HemeSky #MedSky
#Hematology #HemeOnc #HemeSky #MedSky
March 27, 2025 at 7:30 PM
🚨 New Research Alert! 🚨 A machine learning tool is aiding patients with #myelofibrosis and doctors in making better #transplant decisions! Developed by The EBMT, it outperforms traditional methods. Read more in the press release: www.hematology.org/n...
#Hematology #HemeOnc #HemeSky #MedSky
#Hematology #HemeOnc #HemeSky #MedSky
Reposted by HematoRules
Patients with Hodgkin lymphoma refractory/intolerant to both BV & checkpoint inhibitors (an increasing reality in the modern era) have median OS 7.4 yrs. This is a new benchmark in novel trials for R/R cHL. Thank you for the opportunity to participate! #lymsm #medsky
www.nature.com/articles/s41...
www.nature.com/articles/s41...
March 27, 2025 at 10:03 PM
Patients with Hodgkin lymphoma refractory/intolerant to both BV & checkpoint inhibitors (an increasing reality in the modern era) have median OS 7.4 yrs. This is a new benchmark in novel trials for R/R cHL. Thank you for the opportunity to participate! #lymsm #medsky
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by HematoRules
Post-transplant cyclophosphamide in matched donor transplantation, current state of the art 📌
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Post-transplant cyclophosphamide in matched donor transplantation: are we there yet?
Graft-versus-host disease (GvHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (alloHCT) and…
www.sciencedirect.com
February 6, 2025 at 3:52 PM
Post-transplant cyclophosphamide in matched donor transplantation, current state of the art 📌
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by HematoRules
I feel like we could all use something fun to look forward to right about now!!! 🧪🧪🧪
Abstract submission and registration are open for the FASEB Hematologic Malignancies Conference. This is always the BEST meeting!!! Please RT!
events.faseb.org/event/hemato...
Abstract submission and registration are open for the FASEB Hematologic Malignancies Conference. This is always the BEST meeting!!! Please RT!
events.faseb.org/event/hemato...
February 6, 2025 at 5:38 PM
I feel like we could all use something fun to look forward to right about now!!! 🧪🧪🧪
Abstract submission and registration are open for the FASEB Hematologic Malignancies Conference. This is always the BEST meeting!!! Please RT!
events.faseb.org/event/hemato...
Abstract submission and registration are open for the FASEB Hematologic Malignancies Conference. This is always the BEST meeting!!! Please RT!
events.faseb.org/event/hemato...
🎄Merry Xmas🎄
#HematoRulers around the world! Patients, families and colleagues, my best wishes for all of you!
I know some of you are not at your best moment right now, but all of us are rooting for you! We can do this!
We won’t stop until We’ve beaten Blood Cancer! 💪🏼
#HematoRulers around the world! Patients, families and colleagues, my best wishes for all of you!
I know some of you are not at your best moment right now, but all of us are rooting for you! We can do this!
We won’t stop until We’ve beaten Blood Cancer! 💪🏼
December 24, 2024 at 6:56 PM
🎄Merry Xmas🎄
#HematoRulers around the world! Patients, families and colleagues, my best wishes for all of you!
I know some of you are not at your best moment right now, but all of us are rooting for you! We can do this!
We won’t stop until We’ve beaten Blood Cancer! 💪🏼
#HematoRulers around the world! Patients, families and colleagues, my best wishes for all of you!
I know some of you are not at your best moment right now, but all of us are rooting for you! We can do this!
We won’t stop until We’ve beaten Blood Cancer! 💪🏼
Reposted by HematoRules
If you joined @bsky.app during @ash-hematology.bsky.social #ASH24 here’s a starter pack for transplant, cell & gene therapy #bmtsm #CARTcells #generherapy go.bsky.app/7xxh8WW
December 10, 2024 at 5:35 PM
If you joined @bsky.app during @ash-hematology.bsky.social #ASH24 here’s a starter pack for transplant, cell & gene therapy #bmtsm #CARTcells #generherapy go.bsky.app/7xxh8WW
Reposted by HematoRules
#ASH24 plenary: ketogenic diet & CAR-T efficacy
- ketogenic diet➡️cytokine release & CAR expansion in mouse xenograft via beta-hydroxybutyrate
- in pts, BHB correlates w/ CAR expansion and giving BHB to 3 pts enhanced T-cell oxphos
Fascinating! BHB + CAR-T trial is open. #tcellrx
- ketogenic diet➡️cytokine release & CAR expansion in mouse xenograft via beta-hydroxybutyrate
- in pts, BHB correlates w/ CAR expansion and giving BHB to 3 pts enhanced T-cell oxphos
Fascinating! BHB + CAR-T trial is open. #tcellrx
December 8, 2024 at 11:37 PM
Reposted by HematoRules
The slide set is almost ready!!
I am excited to present our data at #ASH24 💪🏼 Thank you @ash-hematology.bsky.social for the opportunity and @haemophage.bsky.social for the phenomenal mentorship 🙌🏼
See you all soon 😍
#MedSky
I am excited to present our data at #ASH24 💪🏼 Thank you @ash-hematology.bsky.social for the opportunity and @haemophage.bsky.social for the phenomenal mentorship 🙌🏼
See you all soon 😍
#MedSky
December 3, 2024 at 3:10 AM
The slide set is almost ready!!
I am excited to present our data at #ASH24 💪🏼 Thank you @ash-hematology.bsky.social for the opportunity and @haemophage.bsky.social for the phenomenal mentorship 🙌🏼
See you all soon 😍
#MedSky
I am excited to present our data at #ASH24 💪🏼 Thank you @ash-hematology.bsky.social for the opportunity and @haemophage.bsky.social for the phenomenal mentorship 🙌🏼
See you all soon 😍
#MedSky
Reposted by HematoRules
#ASH24 Energy matters! Ketogenic Diet Enhances CAR T Cell Antitumor Function Via β-Hydroxybutyrate #CARTCell #TCell #tcellrx #immunotherapy @PennMedicine
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...
a close up of a woman 's face with a surprised look on her face .
ALT: a close up of a woman 's face with a surprised look on her face .
media.tenor.com
December 5, 2024 at 4:49 PM
#ASH24 Energy matters! Ketogenic Diet Enhances CAR T Cell Antitumor Function Via β-Hydroxybutyrate #CARTCell #TCell #tcellrx #immunotherapy @PennMedicine
ash.confex.com/ash/2024/web...
ash.confex.com/ash/2024/web...
Reposted by HematoRules
Four haikus, one post,
A cascade of thought and art—
ASH voices converge.
Thanks @stephxie.bsky.social for the #ASH24 #ASHaiku!
A cascade of thought and art—
ASH voices converge.
Thanks @stephxie.bsky.social for the #ASH24 #ASHaiku!
December 4, 2024 at 10:15 PM
Four haikus, one post,
A cascade of thought and art—
ASH voices converge.
Thanks @stephxie.bsky.social for the #ASH24 #ASHaiku!
A cascade of thought and art—
ASH voices converge.
Thanks @stephxie.bsky.social for the #ASH24 #ASHaiku!
Reposted by HematoRules
17. #MajorPROsASH: Lactuamab CTCL PROs #lymsm
- SS: decreased itch & improved Skindex-29 scores as early as week 5, sustained up to week 45
- MF: PRO improvements occurred later (weeks 29-37)
Differing trajectories of (sustained!) PRO improvements in SS vs MF. #ASH24
- SS: decreased itch & improved Skindex-29 scores as early as week 5, sustained up to week 45
- MF: PRO improvements occurred later (weeks 29-37)
Differing trajectories of (sustained!) PRO improvements in SS vs MF. #ASH24
December 3, 2024 at 10:07 PM
17. #MajorPROsASH: Lactuamab CTCL PROs #lymsm
- SS: decreased itch & improved Skindex-29 scores as early as week 5, sustained up to week 45
- MF: PRO improvements occurred later (weeks 29-37)
Differing trajectories of (sustained!) PRO improvements in SS vs MF. #ASH24
- SS: decreased itch & improved Skindex-29 scores as early as week 5, sustained up to week 45
- MF: PRO improvements occurred later (weeks 29-37)
Differing trajectories of (sustained!) PRO improvements in SS vs MF. #ASH24
Reposted by HematoRules
16. #MajorPROsASH: STARGLO RCT PROs #lymsm #ASH24
- clinically better pain, lymphoma sx w/ glofi at C3 (both arms sig at C5)
- median time to deterioration of fatigue worse with glofi (1.6 v 4 mos)➡️fatigue d/t glofi?
- EOT: sustained improvements in pain & lymphoma sx both arms
- clinically better pain, lymphoma sx w/ glofi at C3 (both arms sig at C5)
- median time to deterioration of fatigue worse with glofi (1.6 v 4 mos)➡️fatigue d/t glofi?
- EOT: sustained improvements in pain & lymphoma sx both arms
December 3, 2024 at 9:30 PM
16. #MajorPROsASH: STARGLO RCT PROs #lymsm #ASH24
- clinically better pain, lymphoma sx w/ glofi at C3 (both arms sig at C5)
- median time to deterioration of fatigue worse with glofi (1.6 v 4 mos)➡️fatigue d/t glofi?
- EOT: sustained improvements in pain & lymphoma sx both arms
- clinically better pain, lymphoma sx w/ glofi at C3 (both arms sig at C5)
- median time to deterioration of fatigue worse with glofi (1.6 v 4 mos)➡️fatigue d/t glofi?
- EOT: sustained improvements in pain & lymphoma sx both arms
Reposted by HematoRules
Please join us in welcoming the incoming 2025 ASH President @b-avalos-md.bsky.social to our thriving Bluesky community! #HemeSky #Hematology #ASH24 🎉
#ASHThrowback to the #ASH16 MMSAP (now HIP) reception, which I am looking forward to attending again at #ASH24. I am also looking forward to receiving the gavel as the incoming
@ash-hematology.bsky.social 2025 president and sharing my experience here! #HemeSky #hematology
@ash-hematology.bsky.social 2025 president and sharing my experience here! #HemeSky #hematology
December 3, 2024 at 6:57 PM
Please join us in welcoming the incoming 2025 ASH President @b-avalos-md.bsky.social to our thriving Bluesky community! #HemeSky #Hematology #ASH24 🎉
Reposted by HematoRules
20. #MajorPROsASH: CLL13 PROs #leusm
- RV/GV: global QOL w/ sustained improvement
- GIV: QOL did not improve during tx!
- median time to improvement fatigue: ~5 mos in RV/GV/GIV arms
- diarrhea worse with GIV vs all other arms
Worse sx burden with GIV! Stick with GV. #ASH24
- RV/GV: global QOL w/ sustained improvement
- GIV: QOL did not improve during tx!
- median time to improvement fatigue: ~5 mos in RV/GV/GIV arms
- diarrhea worse with GIV vs all other arms
Worse sx burden with GIV! Stick with GV. #ASH24
December 3, 2024 at 11:29 PM
20. #MajorPROsASH: CLL13 PROs #leusm
- RV/GV: global QOL w/ sustained improvement
- GIV: QOL did not improve during tx!
- median time to improvement fatigue: ~5 mos in RV/GV/GIV arms
- diarrhea worse with GIV vs all other arms
Worse sx burden with GIV! Stick with GV. #ASH24
- RV/GV: global QOL w/ sustained improvement
- GIV: QOL did not improve during tx!
- median time to improvement fatigue: ~5 mos in RV/GV/GIV arms
- diarrhea worse with GIV vs all other arms
Worse sx burden with GIV! Stick with GV. #ASH24
Reposted by HematoRules
Applications for MSK's QSURE 2025 summer #internship program are now open! This program provides undergraduate students hands-on experience in quantitative science research. Applications are due by 5pm ET on 1/18. Apply ⬇️ www.mskcc.org/departments/...
December 3, 2024 at 7:15 PM
Applications for MSK's QSURE 2025 summer #internship program are now open! This program provides undergraduate students hands-on experience in quantitative science research. Applications are due by 5pm ET on 1/18. Apply ⬇️ www.mskcc.org/departments/...
Reposted by HematoRules
If you haven’t seen it yet, the #ASH24 app allows us to search by disease. I see lots of #hemostasis and #thrombosis to choose from, as well as tons of other other cool science. #hemesky is bright!
Now is the perfect time to download the #ASH24 app! Plan your schedule in advance and access the complete program, full text of all abstracts, maps of the convention center, and much more.
iOS: ow.ly/NQbs50UjV4v
Android: ow.ly/45Zr50UjV4w
#HemeSky #BloodSky #MedSky #Hematology
iOS: ow.ly/NQbs50UjV4v
Android: ow.ly/45Zr50UjV4w
#HemeSky #BloodSky #MedSky #Hematology
December 3, 2024 at 9:36 PM
If you haven’t seen it yet, the #ASH24 app allows us to search by disease. I see lots of #hemostasis and #thrombosis to choose from, as well as tons of other other cool science. #hemesky is bright!